U.S., Jan. 23 -- ClinicalTrials.gov registry received information related to the study (NCT07359430) titled 'Deep Phenotyping of CIndU' on June 11, 2025. Brief Summary: Chronic inducible urticaria (C... Read More
U.S., Jan. 23 -- ClinicalTrials.gov registry received information related to the study (NCT07357636) titled 'Longitudinal Cohort Study of Immune-Related Adverse Events in Solid Tumor Patients Treated ... Read More
U.S., Jan. 23 -- ClinicalTrials.gov registry received information related to the study (NCT07357376) titled 'Evaluating Suzetrigine for Pain Control Following TKA' on Jan. 17. Brief Summary: The goal... Read More
U.S., Jan. 23 -- ClinicalTrials.gov registry received information related to the study (NCT07361042) titled 'Comparison of Video and Classic Laryngeal Mask Airways' on Jan. 05. Brief Summary: The goa... Read More
U.S., Jan. 23 -- ClinicalTrials.gov registry received information related to the study (NCT07360379) titled 'Comparing N-Acetylcysteine (NAC) Versus Alpha-Lipoic Acid (ALA) as Adjuncts for Postoperati... Read More
U.S., Jan. 23 -- ClinicalTrials.gov registry received information related to the study (NCT07360327) titled 'Role of Opioid Free Anaesthesia in Elderly Patients Undergoing Elective Coronary Artery Byp... Read More
U.S., Jan. 23 -- ClinicalTrials.gov registry received information related to the study (NCT07360912) titled 'Haemorrhoidectomy With vs Without Lateral Internal Sphincterotomy' on Jan. 13. Brief Summa... Read More
U.S., Jan. 23 -- ClinicalTrials.gov registry received information related to the study (NCT07359989) titled 'Leucine Plus Radiochemotherapy for Neoadjuvant Treatment of Locally Advanced Rectal Cancer'... Read More
U.S., Jan. 23 -- ClinicalTrials.gov registry received information related to the study (NCT07357727) titled 'A Phase 3 Study of Pelabresib (DAK539) and Ruxolitinib in Myelofibrosis (MF)' on Jan. 15. ... Read More
U.S., Jan. 23 -- ClinicalTrials.gov registry received information related to the study (NCT07357870) titled 'A Proof of Concept, Phase 1 Study of CGB-600 for the Topical Treatment of Non-Segmented Fac... Read More